The mechanism of resistance to sulfa drugs in Plasmodium falciparum

Drug Resistance Updates

Volumn 2, Issue 1, 1999, Pages 15-19

  Triglia, Tony ^a   Cowman, Alan F ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DAPSONE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE; SULFAMETHOXAZOLE; SULFATHIAZOLE; SULFONAMIDE; SULFONE DERIVATIVE;

CROSS RESISTANCE; DRUG MECHANISM; DRUG MIXTURE; DRUG TARGETING; ENZYME ACTIVE SITE; GENE MUTATION; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033081157     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1998.0060     Document Type: Article

References (44)

1. Plowe, C. V. Kublin, J. G. P.falciparum DHFR and DHPS mutations: epidemiology and role in clinical resistance to antifolates, Drug Resistance Updates 1998.
2. Wernsdorfer, W. H. The importance of malaria in the world. Kreier, J. P. (ed. Malaria. Epidemiology, Chemotherapy, Morphology, and Metabolism, New York, Academic Press, 1-93.
3. Peters W. The problem of drug resistance in malaria. Parasitology. 90:1985;705-715.
4. Woods D. D. The relation of p -aminobenzoic acid to the mechanism of the action of sulphanilamide. Br J Exp Path. 21:1940;74-90.
5. Miller A. K. Folic acid and biotin synthesis by sulfonamide-sensitive and sulfonamide-resistant strains of Escherichia coli. Proc Soc Exp Biol Med. 57:1944;151-153.
6. Scholer, H. J. Leimer, R. Richle, R. Sulphonamides and sulphones. Peters, W.Richards, W. H. G. Antimalarial drugs. Current antimalarials and new drug developments, Springer-Verlag, 123-206.
7. Bloland P., Slutsker L., Steketee R. W., Wirima J. J., Heymann D. L., Breman J. G. Rates and risk factors for mortality during the first two years of life in rural Malawi. Am J Trop Med Hyg. 55:1996;82-86.
8. Landgraf B., Kollaritsch H., Wiedermann G., Wernsdorfer W. H. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanian schoolchildren. Trans R Soc Trop Med Hyg. 88:1994;440-442.
9. Rollo I. M. The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum. Br J Pharmacol. 10:1955;208-214.
10. Bishop A. Some recent developments in the problem of drug resistance in malaria. Parasitology. 53:1963;10.
11. McCormick G. J., Canfield C. J., Willet G. P. Plasmodium knowlesi: in vitro evaluation of anti-malarial activity of folic acid inhibitors. Exp Parasitol. 30:1971;88-93.
12. Tan Ariya P., Brockelman C. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 15:1984;7-11.
13. Watkins W. M., Sixsmith D. G., Chulay J. D. The activity of proguanil and its metabolites, cycloguanil and p -chlorophenylbiguanide, against Plasmodium falciparum in vitro. Am J Trop Med Hyg. 78:1984;273-278.
14. Watkins W. M., Sixsmith D. G., Chulay J. D., Spencer H. C. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p -aminobenzoic acid, p -aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol. 14:1985;55-61.
15. Ferone R. Folate metabolism in malaria. Bull WHO. 55:1977;291-298.
16. Sherman I. W. Biochemistry of Plasmodium (malarial parasites). Microbiol Rev. 43:1979;453-495.
17. Krungkrai J., Webster H. K., Yuthavong Y. De novo and salavage biosynthesis of pterolpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol. 32:1989;25-38.
18. Krungkrai J., Yuthavong Y., Webster H. K. Guanosine triphosphate cyclohydrolase in Plasmodium falciparum and other Plasmodium species. Mol Biochem Parasitol. 17:1985;265-276.
19. Schellenberg K. A., Coatney G. R. The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. Biochem Pharmacol. 6:1961;143-152.
20. Gutteridge W. E., Trigg P. I. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitro. Parasitology. 62:1971;431-444.
21. Newbold C. I., Boyle D. B., Smith C. C., Brown K. N. Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi. Mol Biochem Parasitol. 5:1982;33-44.
22. Gritzmacher C. A., and Reese R. T. Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum. J Bacteriol. 160:1984;1165-1167.
23. Inselburg J., Banyal H. S. Synthesis of DNA during the asexual cycle of Plasmodium falciparum in culture. Mol Biochem Parasitol. 10:1984;79-87.
24. Janse C. J., van der Klooster P. F., van der Kaay H. J., van der Ploeg M., Overdulve J. P. DNA synthesis in Plasmodium berghei during asexual and sexual development. Mol Biochem Parasitol. 20:1986;173-182.
25. Banyal H. S., and Inselburg J. Plasmodium falciparum: induction, selection, and characterization of pyrimethamine-resistant mutants. Exp Parasitol. 62:1986;61-70.
26. Ferone R. The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. J Protozool. 20:1973;459-463.
27. McCullough J., Maren T. A. Dihydropteroate synthetase from Plasmodium berghei: isolation, properties and inhibition by dapsone and sulfadiazine. Mol Pharmacol. 10:1974;140-145.
28. Walter R. D., Konigk E. 7,8-Dihydropteroate-synthesizine enzyme from Plasmodium chabaudi. Meths Enzymol. 66:1980;564-570.
29. Zhang Y., Meshnick S. R. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs. Antimicrob Agents Chemother. 35:1991;267-271.
30. Triglia T., Menting J. G. T., Wilson C., Cowman A. F. Mutations of dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 94:1997;13944-13949.
31. Dieckmann A., Jung A. Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Mol Biochem Parasitol. 19:1986;143-147.
32. Triglia T., Cowman A. F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 91:1994;7149-7153.
33. Brooks D., Wang P., Read M., Watkin W., Sims P., Hyde J. Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 224:1994;397-405.
34. Wang P., Read M., Sims P. F. G., Hyde J. E. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilisation. Mol Microbiol. 23:1997;979-986.
35. Walter R. D., Konigk E. Purification and properties of the 7,8 dihydropteroate synthesizine enzyme from Plasmodium chabaudi. Z Phys Chem. 335:1974;431-437.
36. Wu Y., Kirkman L. A., Wellems T. E. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA. 93:1996;1130-1134.
37. Crabb B. S., Cowman A. F. Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. Proc Natl Acad Sci. 93:1996;7289-7294.
38. Triglia T., Wang P., Sims P. F. G., Hyde J. E., Cowman A. F. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 17:1998;3807-3815.
39. Achari A., Somers D. O., Champness J. N., Bryant P. K., Rosemond J., Stammers D. K. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nature Struct Biol. 4:1997;490-497.
40. Hampele I. C., D'Arcy A., Dale G. E. Structure and function of the dihydropteroate synthase from Staphylococcus aureus. J Mol Biol. 268:1997;21-30.
41. Fermer C., Kristiansen B-E., Skold O., Swedberg G. Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. J Bacteriol. 177:1995;4669-4675.
42. Maskell J. P., Sefton A. M., Hall L. M. Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 41:1997;2121-2126.
43. Vedantam G., Nichols B. P. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance inEscherichia coli. Microb Drug Resist. 4:1998;91-97.
44. Sirawaraporn W., Sathitkul T., Sirawaraporn R., Yuthavong Y., Santi D. V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA. 94:1997;1124-1129.